Apply For Grant Funding
2023 Precision Oncology Research Grants
Canadian scientists and researchers are invited to submit an application for precision oncology breast cancer research projects by December 23, 2022.
Breast Cancer Canada has announced a call for proposals for their 2023 Precision Oncology Research Grants which will award $500,000 in new funding for breast cancer research projects. The submission period will close December 23, 2022.
Thanks to the generous support of Breast Cancer Canada donors through 2022, the organization has increased their new grants funding for the year ahead by $150,000 for their second annual call for proposals. The organization granted $350,000 in funding to precision oncology projects across Canada in 2022, many of which are continuing into the new year.
“With several Canadian organizations having to reduce funding for breast cancer research, we are proud to continue elevating precision oncology research projects that will have direct impact on patients,” said Shaniah Leduc, Chair of Breast Cancer Canada. “We know because of research there are more than 50 types of breast cancer. Precision oncology research allows us to more accurately diagnose breast cancer, and design treatment plans targeted to the patient’s specific type of breast cancer – the goal is to match the right treatment, to the right person, at the right time.”
Breast Cancer Canada’s Scientific Advisory Committee is leading the selection process and is committed to listening to breast cancer patients. All funded project teams are required to include a breast cancer patient advocate or a local breast cancer advocacy group as part of their research.
The selected projects will focus on precision oncology that deliver individualized treatment models and accelerate the transition from standard approaches for breast cancer treatment, to the new age of personalized medicine. The projects will surround four divisions of precision oncology research: basic science, screening and detection, personalized treatment, and patient reported outcomes. All projects must also include an artificial intelligence (AI) component.
Canadian scientists and researchers are invited to submit an application for precision oncology breast cancer research projects by December 23, 2022. Please download the application package here which includes details on the eligibility, mandate, and timeline.
Questions can be directed to: [email protected]
Scientific Advisory Board
Breast Cancer Canada remains the only organization in Canada laser focused on breast cancer research. The projects we fund surround precision oncology set to deliver individualized treatment plans. Progress starts with the right people. The teams we leverage across Canada accelerate the transition from standard approaches for breast cancer treatment, to the new age of personalized medicine. Our ultimate goal is to match the right plan, to the right person, at the right time.
Dr. Marc Webster
Chair, Scientific Advisory Committee
Breast Cancer Research Focused in Precision Oncology
Breast Cancer Canada’s Scientific Advisory Board works as one to drive excellence in Canadian breast cancer research and leadership. How? By identifying, collaborating with, and funding groups and individuals. Specifically, those that are supporting our four pillars in precision oncology research. The pillars that bring us closer to earlier detection and better management.
Our research focuses on precision oncology that deliver individualized treatment models. The projects we fund across Canada accelerate the transition from standard approaches for breast cancer treatment, to the new age of personalized medicine.
The goal is to match the right plan to the right person at the right time.
Precision Genomics Research Pillars
The purpose of basic science research is to increase the understanding of how fundamental biological processes work. The information uncovered by basic science projects lay the groundwork for all other research that follows.
Using new technology to improve screening and detection – with better quality and less invasive test techniques than what we use now. New precision or personalized technology like genomic blood tests that identify breast cancer during screening, and machine learning that assists a clinician for more accurate breast cancer detection.
Research where a biomarker has been identified for treatment research and development; or a targeted localized treatment discovery is in early stage of development involving a precision oncology focus.
Patient Reported Outcomes
Research on the implementation of patient reported outcomes across the spectrum of breast cancer screening and disease management. The data highlights how patients perceive health and treatment effects and how treatments impact outcomes. This shapes treatment and surgical interventions that impact many aspects of a patient’s life.